ClinicalTrials.govpublic full text
Sustained Virological Suppression and Improvement of Adverse Events of Switching to Raltegravir Study
hiv infection, adverse drug reaction, quality of life, raltegravir, adverse event, life quality, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 871600
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.